COPD - Nursing Case Study
Pathophysiology
• Primary mechanism: Chronic inflammation in the airways leads to irreversible airflow limitation. Inflammatory cells release enzymes that damage lung tissue, resulting in narrowed airways and destruction of alveoli, reducing gas exchange.
• Secondary mechanism: Mucus hypersecretion occurs due to persistent irritation, leading to airway obstruction. Goblet cells and submucosal glands increase mucus production, further narrowing airways and causing difficulty in breathing.
• Key complication: Air trapping and hyperinflation develop as damaged airways collapse during exhalation, increasing lung volume and flattening the diaphragm. This impairs respiratory mechanics and exacerbates breathlessness.
Patient Profile
Demographics:
65-year-old male, retired coal miner
History:
• Key past medical history: Chronic obstructive pulmonary disease (COPD) diagnosed 5 years ago, hypertension, and type 2 diabetes
• Current medications: Tiotropium, Salbutamol inhaler, Metformin, Lisinopril
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increasing shortness of breath and productive cough
• Key symptoms: Wheezing, fatigue, occasional chest tightness, sputum production with mild hemoptysis
• Vital signs: Blood pressure 150/95 mmHg, heart rate 105 bpm, respiratory rate 24 breaths per minute, oxygen saturation 88% on room air, temperature 37.2°C (99°F)
Section 1
New Complications:
During the hospital stay, the patient began exhibiting increased respiratory distress, with a respiratory rate escalating to 30 breaths per minute despite being on supplemental oxygen at 2 liters per minute via nasal cannula. His oxygen saturation remained concerning at 85%, prompting further evaluation. Auscultation revealed diminished breath sounds in the lower lung fields bilaterally, along with increased wheezing and rhonchi. The productive cough became more persistent, and the hemoptysis, initially mild, appeared to increase slightly. These observations suggested the potential development of a secondary infection or an acute exacerbation of COPD.
Laboratory results soon confirmed the suspicion of a bacterial infection; the sputum culture grew Pseudomonas aeruginosa, a common pathogen in COPD exacerbations. A chest X-ray showed increased opacities in the right lower lobe, consistent with pneumonia. Given his allergy to penicillin, the medical team initiated treatment with a fluoroquinolone antibiotic, levofloxacin, to target the resistant organism. Concurrently, systemic corticosteroids were started to manage inflammation, and bronchodilator therapy was optimized.
The emergence of pneumonia as a complication necessitated a revision of the patient's care plan. The focus shifted to aggressively managing the infection while carefully monitoring respiratory status and adjusting interventions as needed. This development required nursing staff to engage in diligent respiratory assessments, identify any signs of further deterioration, and ensure timely communication with the interdisciplinary team for potential escalation of care. The combination of COPD exacerbation and pneumonia posed a significant challenge, demanding comprehensive clinical reasoning and vigilant monitoring to stabilize the patient and prevent further complications.
Section 2
Response to Interventions:
Following the initiation of levofloxacin and systemic corticosteroids, the patient’s status was closely monitored to evaluate the effectiveness of the treatment. Within 48 hours, there was a noticeable reduction in wheezing, and his cough became less productive, suggesting a positive initial response to the antibiotic therapy. However, his respiratory rate remained elevated at 28 breaths per minute, and oxygen saturation modestly improved to 88% on 3 liters of supplemental oxygen via nasal cannula. Despite these improvements, the patient continued to experience significant dyspnea, particularly when attempting minimal physical activity, such as repositioning in bed or using the bedside commode.
Arterial blood gas analysis was conducted to further assess respiratory function, revealing persistent respiratory acidosis with a pH of 7.32, elevated PaCO2 at 58 mmHg, and PaO2 at 68 mmHg. These findings indicated ongoing hypoventilation and impaired gas exchange. Additionally, laboratory tests showed a white blood cell count of 14,500/mm³, down from a peak of 18,000/mm³, reflecting a partial response to infection management but suggesting that the inflammatory process was still active.
The medical team decided to introduce non-invasive ventilation (NIV) to alleviate the respiratory acidosis and improve oxygenation. The use of NIV, such as bilevel positive airway pressure (BiPAP), was aimed at reducing the work of breathing and enhancing alveolar ventilation. Nursing staff were tasked with closely monitoring the patient's tolerance to BiPAP, ensuring proper mask fit, and observing for any signs of intolerance or complications such as gastric distension or skin breakdown. The interdisciplinary team remained vigilant for any signs of further deterioration, ready to escalate care if necessary. This approach required careful balancing of interventions to maximize respiratory support while minimizing patient discomfort and avoiding further complications.
Section 3
New Complications
Despite the introduction of non-invasive ventilation and the initial positive response to the treatment regimen, the patient began to exhibit new complications indicative of further clinical deterioration. Within 24 hours of starting BiPAP, the patient developed increased anxiety and restlessness, particularly when the mask was applied. His respiratory rate climbed to 32 breaths per minute, and he reported a sensation of air hunger despite the supportive ventilation. These symptoms, coupled with a persistent SpO2 of 85% on BiPAP, suggested that the current non-invasive support might be insufficient to meet his respiratory needs.
A repeat arterial blood gas analysis was performed, revealing worsening respiratory acidosis with a pH now at 7.28, PaCO2 increased to 62 mmHg, and PaO2 decreased to 64 mmHg. These results indicated a deteriorating gas exchange and a failure to adequately ventilate, raising concerns about impending respiratory failure. Moreover, auscultation of the lungs revealed diminished breath sounds bilaterally, and the patient’s increased work of breathing was evident through the use of accessory muscles and paradoxical abdominal movements.
The interdisciplinary team convened to reassess the patient's condition, recognizing the need to escalate respiratory support. The potential for transitioning to invasive mechanical ventilation was discussed, balancing the risks and benefits given the patient's overall status and comorbidities. Nursing staff prepared to facilitate this transition, ensuring the availability of necessary equipment and the readiness of the critical care team. Meanwhile, efforts were made to address the patient’s anxiety and discomfort, with the administration of low-dose anxiolytics and optimization of his positioning to maximize comfort and respiratory efficacy. This evolving situation required vigilant monitoring and prompt intervention to prevent further complications and stabilize the patient’s condition.
Section 4
New Diagnostic Results
Following the decision to escalate care, additional diagnostic evaluations were conducted to gain further insight into the patient’s deteriorating condition. A chest X-ray was performed to assess for any potential complications such as pneumothorax or pneumonia that could be contributing to the worsening respiratory status. The imaging revealed increased bilateral infiltrates, suggesting the development of an acute exacerbation of COPD potentially complicated by pneumonia. This finding prompted the initiation of broad-spectrum antibiotic therapy to address the suspected infection, while awaiting sputum culture results for targeted treatment.
Concurrently, laboratory tests were ordered to evaluate the patient’s metabolic status and rule out other contributing factors to his respiratory distress. The complete blood count (CBC) showed leukocytosis with a white blood cell count of 15,000 cells/µL, further supporting the likelihood of an infectious process. Additionally, electrolytes were monitored closely, revealing a mild hypokalemia with a potassium level of 3.2 mEq/L, necessitating careful replacement to prevent cardiac complications and support muscular function, especially in the context of increased respiratory effort.
These new diagnostic results provided a more comprehensive understanding of the patient’s condition, highlighting the complexity of his clinical picture. The interdisciplinary team revisited the treatment plan, emphasizing the importance of addressing both the respiratory failure and the underlying infection. The team also remained vigilant for any signs of further complications, such as sepsis or cardiac arrhythmias, requiring continuous monitoring and timely intervention to optimize the patient's outcomes as they prepared for the possible transition to invasive mechanical ventilation.
Section 5
New Complications
Despite the initiation of broad-spectrum antibiotics and electrolyte management, the patient's condition continued to evolve, presenting new complications. Over the next 24 hours, the patient exhibited signs of increased respiratory distress, characterized by a respiratory rate climbing to 32 breaths per minute with accessory muscle use and audible wheezing. Oxygen saturation dropped to 88% on supplemental oxygen via a non-rebreather mask. The patient also developed a productive cough with purulent sputum, which was concerning for a worsening pneumonia.
Further laboratory evaluations were conducted, including an arterial blood gas (ABG) analysis, revealing a pH of 7.30, PaCO2 of 55 mmHg, and PaO2 of 60 mmHg, indicating a primary respiratory acidosis with inadequate compensation. These findings suggested that the patient's respiratory muscles were becoming fatigued, and he was struggling to maintain adequate ventilation. Given the increasing hypoxemia and hypercapnia, the healthcare team recognized the potential need for mechanical ventilation to support the patient's respiratory function and prevent respiratory failure.
In addition to the respiratory concerns, the patient developed tachycardia with a heart rate of 120 bpm and an irregular rhythm, raising suspicion for atrial fibrillation, likely exacerbated by hypoxia and electrolyte imbalances. An immediate EKG confirmed atrial fibrillation with rapid ventricular response. This arrhythmia posed a significant risk for further hemodynamic instability and required prompt management, including rate control and anticoagulation considerations to prevent thromboembolic events. The team prepared to implement a comprehensive management plan, addressing both the respiratory and cardiac complications to stabilize the patient and prevent further deterioration.